Your browser doesn't support javascript.
loading
Endothelial Calcineurin Signaling Restrains Metastatic Outgrowth by Regulating Bmp2.
Hendrikx, Stefanie; Coso, Sanja; Prat-Luri, Borja; Wetterwald, Laureline; Sabine, Amélie; Franco, Claudio A; Nassiri, Sina; Zangger, Nadine; Gerhardt, Holger; Delorenzi, Mauro; Petrova, Tatiana V.
Afiliação
  • Hendrikx S; Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Division of Experimental Pathology, CHUV, Epalinges 1066, Switzerland.
  • Coso S; Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Division of Experimental Pathology, CHUV, Epalinges 1066, Switzerland.
  • Prat-Luri B; Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Division of Experimental Pathology, CHUV, Epalinges 1066, Switzerland.
  • Wetterwald L; Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Division of Experimental Pathology, CHUV, Epalinges 1066, Switzerland.
  • Sabine A; Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Division of Experimental Pathology, CHUV, Epalinges 1066, Switzerland.
  • Franco CA; Instituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Nassiri S; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland; Translational Bioinformatics and Statistics, Swiss Cancer Center Lausanne, Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland.
  • Zangger N; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland; Translational Bioinformatics and Statistics, Swiss Cancer Center Lausanne, Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland.
  • Gerhardt H; Vascular Patterning Laboratory, Department of Oncology, KU Leuven, Leuven, Belgium; Integrative Vascular Biology Laboratory, Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin Institute of Health (BIH), German Center for Cardiovascular Research (DZHK) Partner Site,
  • Delorenzi M; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland; Translational Bioinformatics and Statistics, Swiss Cancer Center Lausanne, Department of Oncology, University of Lausanne, Lausanne 1
  • Petrova TV; Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland; Division of Experimental Pathology, CHUV, Epalinges 1066, Switzerland; Swiss Institute for Cancer Research, École Polytechnique Fédérale de Lausanne, Laus
Cell Rep ; 26(5): 1227-1241.e6, 2019 01 29.
Article em En | MEDLINE | ID: mdl-30699351
ABSTRACT
Calcineurin/NFAT signaling is active in endothelial cells and is proposed to be an essential component of the tumor angiogenic response. Here, we investigated the role of endothelial calcineurin signaling in vivo in physiological and pathological angiogenesis and tumor metastasis. We show that this pathway is dispensable for retinal and tumor angiogenesis, but it is implicated in vessel stabilization. While ablation of endothelial calcineurin does not affect the progression of primary tumors or tumor cell extravasation, it does potentiate the outgrowth of lung metastases. We identify Bmp2 as a downstream target of the calcineurin/NFAT pathway in lung endothelium, potently inhibiting cancer cell growth by stimulating differentiation. We reveal a dual role of calcineurin/NFAT signaling in vascular regression or stabilization and in the tissue-specific production of an angiocrine factor restraining cancer cell outgrowth. Our results suggest that, besides targeting the immune system, post-transplantation immunosuppressive therapy with calcineurin inhibitors directly targets the endothelium, contributing to aggressive cancer progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Calcineurina / Células Endoteliais / Proteína Morfogenética Óssea 2 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Calcineurina / Células Endoteliais / Proteína Morfogenética Óssea 2 Idioma: En Ano de publicação: 2019 Tipo de documento: Article